Experts are calling for a common women’s health condition, polycystic ovarian syndrome (PCOS) , to be renamed, arguing that the current title contributes to delayed diagnoses. The condition, which affects around one in eight women, is often misunderstood due to its name’s overemphasis on ovarian cysts and the ovaries, they say. PCOS is a complex, long-term hormonal or endocrine disorder, impacting weight, skin, metabolic and mental health , and the reproductive system. A new consensus statement in The Lancet proposes the new name polyendocrine metabolic ovarian syndrome (PMOS). NHS officials have confirmed the recommendation will be “carefully considered”. The proposed name change comes after engagement with academics, patient and clinical groups as well as global surveys of thousands of patients with the condition.…